18F-FDG PET-CT鉴别子宫内膜生理性摄取与IA期子宫内膜癌的应用价值分析
前瞻性纳入354例无妇科疾病、无激素使用女性(生理组)和42例IA期子宫内膜癌患者,按月经周期分5组分析18F-FDG PET-CT摄取。月经期和排卵期摄取较高、多为三角形;子宫内膜癌摄取显著更高、多为类圆形、椭圆形和不规则形,结合形态可有效鉴别。
要点
- 月经期和排卵期子宫内膜18F-FDG摄取较高,形态以三角形为主。
- IA期子宫内膜癌摄取显著高于月经期、排卵期生理性摄取,形态以类圆形、椭圆形和不规则形为主。
- 排卵期SUVmax≥5.96、R/L≥2.85时,结合月经周期和浓聚形态可有效鉴别生理性摄取与IA期子宫内膜癌。
核心结论
- 18F-FDG PET-CT显像子宫内膜在月经期、排卵期摄取较高,形态主要为三角形;子宫内膜癌摄取显著高于月经期、排卵期生理性摄取,形态主要为圆形、椭圆形和不规则形。
- 当最佳截断值SUVmax≥5.96、R/L值≥2.85时,结合放射性浓聚的形态特征可有效鉴别生理性摄取与IA期子宫内膜癌。
研究设计与样本
- 前瞻性纳入2022年9月至2024年4月于青岛大学附属医院行18F-FDG PET-CT检查的354例无妇科疾病、无激素使用的女性设为生理组,另设42例IA期子宫内膜癌组。
- 生理组按月经周期分为月经期、增殖期、排卵期、分泌期和绝经期共5组。
- 采用视觉分析和定量测定分析图像,定量指标为SUVmax和感兴趣区/肝比值(R/L值);采用受试者操作特征(ROC)曲线确定SUVmax和R/L值的最佳截断值。
- 采用二元logistic回归建立临床模型,绘制ROC曲线评估模型的预测效能。
主要发现
- 月经期SUVmax为6.66±3.26、排卵期SUVmax为3.89±1.21,显著高于增殖期SUVmax中位数2.54(2.02,3.47)、分泌期SUVmax为2.55±0.86和绝经期SUVmax中位数2.04(1.69,2.29)。
- 月经期和排卵期放射性浓聚形态呈三角形105例、椭圆形32例、类圆形2例;42例子宫内膜癌均呈18F-FDG摄取,类圆形17例、椭圆形10例、三角形9例、不规则形6例。
- 月经期、排卵期与子宫内膜癌放射性浓聚形态差异均具有统计学意义(均P<0.001)。
- 月经期子宫内膜SUVmax为6.66±3.26、R/L值为2.65±1.32,排卵期SUVmax为3.89±1.21、R/L值为1.52±0.48;子宫内膜癌组SUVmax为14.87±5.75、R/L值为5.07±2.03;月经期和排卵期与子宫内膜癌组的SUVmax和R/L值差异均具有统计学意义(均P<0.001)。
- 月经期SUVmax、R/L值最佳截断值分别为12.59、3.81,AUC分别为0.885、0.842;结合摄取形态构建模型后AUC分别为0.969、0.948。排卵期SUVmax、R/L值最佳截断值分别为5.96、2.85,AUC分别为0.984、0.968;结合摄取形态构建模型后AUC分别为0.999、0.998。
关键数值与推荐
- 月经期鉴别子宫内膜生理性摄取与IA期子宫内膜癌的SUVmax最佳截断值为12.59、R/L值最佳截断值为3.81,AUC分别为0.885、0.842。
- 排卵期鉴别子宫内膜生理性摄取与IA期子宫内膜癌的SUVmax最佳截断值为5.96、R/L值最佳截断值为2.85,AUC分别为0.984、0.968。
- 结合子宫内膜摄取形态构建模型后,月经期AUC分别为0.969、0.948,排卵期AUC分别为0.999、0.998。
临床怎么用
- 原文结论认为,当SUVmax≥5.96、R/L值≥2.85时,结合受试者生理周期和放射性浓聚形态特征,可有效鉴别生理性摄取与IA期子宫内膜癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the uptake patterns of 18F-fluorodeoxy glucose (18F-FDG) in the endometrium using positron emission tomography (PET) imaging and to differentiate these from stage IA endometrial cancer. Methods: From September 2022 to April 2024, a prospective inclusion of 354 women without gynecological diseases and no hormone usage who underwent 18F-FDG PET-CT examinations at the affiliated hospital of Qingdao University were set as the physiological group, while a group containing 42 cases of Stage IA endometrial carcinoma was also set. The physiological group was divided into five groups based on the menstrual cycle: menstrual period, proliferative phase, ovulatory phase, secretory phase, and menopausal phase. The images were analyzed using visual and quantitative measurements; quantitative analysis indicators were standardized uptake value maximum (SUVmax) and the region of interest/liver ratio (R/L value). Receiver operating characteristic (ROCs) curve was used to determine the optimal cutoff values for SUVmax and R/L value. A clinical model was established using binary logistic regression, and ROC curves were drawn to evaluate the predictive performance of the model. Results: The uptake of 18F-FDG in the endometrium exhibited cyclical variations throughout different physiological phases, with higher uptakes observed during the menstrual and ovulation phases (SUVmax values of 6.66±3.26 and 3.89±1.21, respectively), which are significantly higher than those in the proliferative phase [median SUVmax of 2.54 (2.02, 3.47)], secretory phase (SUVmax of 2.55±0.86), and menopausal phase [SUVmax median of 2.04 (1.69, 2.29)]. During the menstrual and ovulation phases, the radiotracer accumulation patterns were triangular in 105 cases, oval in 32 cases, and round-like in 2 cases. All 42 cases of endometrial cancer showed 18F-FDG uptake, with radiotracer accumulation patterns being round-like in 17 cases, oval in 10 cases, triangular in 9 cases, and irregular in 6 cases. There were statistically significant differences in the shapes of radiotracer concentration between the menstrual, ovulatory periods, and endometrial carcinoma (both P<0.001). The SUVmax and R/L values in menstrual period and ovulatory period were significantly lower than that in endometrial carcinoma group (P<0.001). During the menstrual phase, the optimal cutoff values for SUVmax and R/L in distinguishing between endometrial and endometrial cancer were 12.59 and 3.81, respectively, with corresponding AUCs of 0.885 and 0.842. After incorporating endometrial uptake morphology into the model, the AUCs was improved to 0.969 and 0.948, respectively. During the ovulatory phase, the optimal cutoff values for SUVmax and R/L were 5.96 and 2.85, respectively, with AUCs of 0.984 and 0.968. After integrating endometrial uptake morphology into the model, the AUCs were increased to 0.999 and 0.998, respectively. Conclusions: The 18F-FDG PET imaging of the endometrium shows higher uptake during the menstrual and ovulatory periods, primarily triangular in shape; endometrial carcinoma uptake is significantly higher than the physiological uptake during the menstrual and ovulatory periods, mainly in circular, oval, and irregular shapes. When SUVmax≥5.96, R/L≥2.85, combined with the physiological cycle of the subjects and the morphological characteristics of the radiotracer concentration, it is possible to effectively differentiate between physiological uptake and Stage IA endometrial carcinoma. 目的: 研究18F-脱氧葡萄糖(18F-FDG)正电子发射计算机断层扫描(PET-CT)显像子宫内膜摄取状态,并与ⅠA期子宫内膜癌进行鉴别。 方法: 前瞻性纳入2022年9月至2024年4月于青岛大学附属医院行18F-FDG PET-CT检查的354例无妇科疾病、无激素使用的女性设为生理组和42例ⅠA期子宫内膜癌组。生理组按月经周期分为月经期、增殖期、排卵期、分泌期和绝经期,共5组。采用视觉分析和定量测定对图像进行分析,定量分析指标为最大标准化摄取值(SUVmax)和感兴趣区/肝比值(R/L值)。采用Kruskal-Wallis H、Mann-Whitney U、Nemenyi、独立样本t检验、Fisher确切概率法分析数据,受试者操作特征(ROC)曲线确定SUVmax和R/L值的最佳截断值。采用二元logistic回归建立临床模型,绘制ROC曲线评估模型的预测效能。 结果: 子宫内膜在不同生理周期对18F-FDG摄取呈周期性变化,月经期和排卵期摄取较高(SUVmax分别为6.66±3.26、3.89±1.21),显著高于增殖期[SUVmax中位数2.54(2.02,3.47)]、分泌期(SUVmax为2.55±0.86)和绝经期[SUVmax中位数2.04(1.69,2.29)]。月经期和排卵期放射性浓聚形态呈三角形105例、椭圆形32例、类圆形2例;42例子宫内膜癌均有18F-FDG摄取,放射性浓聚形态呈类圆形17例、椭圆形10例、三角形9例、不规则形6例。月经期、排卵期与子宫内膜癌放射性浓聚形态差异均具有统计学意义(均P<0.001)。月经期子宫内膜SUVmax为6.66±3.26、R/L值为2.65±1.32,排卵期SUVmax为3.89±1.21、R/L值为1.52±0.48,子宫内膜癌组SUVmax为14.87±5.75、R/L值为5.07±2.03。月经期和排卵期与子宫内膜癌组的SUVmax和R/L值差异均具有统计学意义(均P<0.001)。月经期子宫内膜与子宫内膜癌的SUVmax、R/L值最佳截断值分别为12.59、3.81,鉴别生理性摄取与ⅠA期子宫内膜癌的曲线下面积(AUC)分别为0.885、0.842;结合子宫内膜摄取形态构建模型后,其AUC分别为0.969、0.948。排卵期子宫内膜与子宫内膜癌的SUVmax、R/L值最佳截断值分别为5.96、2.85,AUC分别为0.984、0.968;结合子宫内膜摄取形态构建模型后,其AUC分别为0.999、0.998。 结论: 18F-FDG PET-CT显像子宫内膜在月经期、排卵期摄取较高,形态主要为三角形;子宫内膜癌摄取显著高于月经期、排卵期生理性摄取,形态主要为圆形、椭圆形和不规则形。当最佳截断值SUVmax≥5.96、R/L值≥2.85时,结合放射性浓聚的形态特征可有效鉴别生理性摄取与ⅠA期子宫内膜癌。.
引用
- Gao CL, Yang GJ, An L, et al. [Analysis of the application value of 18F-FDG PET-CT in differentiating physiological uptake in the endometrium from stage IA endometrial carcinoma]. Zhonghua Zhong Liu Za Zhi. 2025. PMID: 40268553. doi:10.3760/cma.j.cn112152-20241009-00434
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。